NZOZ Specjal. Osrodek Dermatologiczny DERMAL
- Address
- Ul. Nowy Swiat 17/5, 15-453 Bialystok, Poland
NZOZ Specjal. Osrodek Dermatologiczny DERMAL - Specialized Dermatology Center
NZOZ Specjal. Osrodek Dermatologiczny DERMAL is a specialized dermatology research center focused on advancing treatment options for complex and chronic skin conditions. The center demonstrates particular expertise in investigating novel therapeutic approaches for challenging dermatological disorders that significantly impact patients' quality of life.
- Hidradenitis suppurativa (HS) clinical trials and management
- Innovative biologic and targeted therapies for inflammatory skin diseases
- Phase 2 efficacy and safety studies in moderate to severe dermatological conditions
The research center actively participates in international clinical trials evaluating cutting-edge treatments for moderate to severe hidradenitis suppurativa, a chronic inflammatory skin condition. Through rigorous randomized, double-blind, placebo-controlled studies, DERMAL contributes to the development of novel therapeutic options that address unmet medical needs in dermatology, helping to establish new standards of care for patients with debilitating skin diseases.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1Incyte Corp.1active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Incyte Corp.2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in NZOZ Specjal. Osrodek Dermatologiczny DERMAL
lock Showing 1 of 14 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A multicentre, randomised, double-blind, placebo-controlled, 12-week parallel-group trial to evaluate the efficacy and safety of oral BP1.7881 in adult patients with moderate-to-severe atopic dermatitis | Bioprojet Pharma | Phase II | Not Recruiting | Aug 2023 | Jun 2024 |
IMP list
lock Showing 1 of 12 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| 4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide | 2 | Unknown | 2024-12-12 | 2025-09-03 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.